|
|
|||
| |||||||||||||||||||||||||||||||||||||||
In fiscal year 2003, $1.5 billion was allocated for biodefense research to the National Institutes of Health (NIH). These new research dollars, which have been
Source Information
Dr. Relman is an associate professor in the Departments of Medicine and of Microbiology and Immunology, Stanford University, Stanford, Calif., chief of infectious diseases at the Veterans Affairs Palo Alto Health Care System, Palo Alto, Calif., and a member of the National Science Advisory Board for Biosecurity.
An interview with Dr. Relman can be heard at www.nejm.org.
This article has been cited by other articles:
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |